HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christoph C Zielinski Selected Research

GET protocol

12/2003Gemcitabine, anthracycline, and taxane combinations for advanced breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christoph C Zielinski Research Topics

Disease

75Neoplasms (Cancer)
05/2022 - 10/2003
55Breast Neoplasms (Breast Cancer)
05/2022 - 05/2002
12Renal Cell Carcinoma (Grawitz Tumor)
01/2016 - 11/2003
9Brain Neoplasms (Brain Tumor)
01/2019 - 09/2006
9Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 10/2003
9Disease Progression
03/2013 - 03/2004
8Neoplasm Metastasis (Metastasis)
05/2022 - 05/2003
6Melanoma (Melanoma, Malignant)
01/2021 - 01/2005
5Sarcoma (Soft Tissue Sarcoma)
01/2019 - 05/2006
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 03/2012
5Ovarian Neoplasms (Ovarian Cancer)
05/2018 - 12/2005
5Lung Neoplasms (Lung Cancer)
10/2014 - 09/2005
5Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
02/2014 - 11/2005
4Carcinoma (Carcinomatosis)
05/2018 - 01/2005
3Colonic Neoplasms (Colon Cancer)
01/2016 - 11/2005
3Multiple Myeloma
02/2015 - 06/2004
3Necrosis
01/2014 - 06/2002
3Lymphoma (Lymphomas)
01/2006 - 02/2005
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2017 - 08/2016
2Adenocarcinoma
01/2017 - 06/2008
2Kidney Neoplasms (Kidney Cancer)
01/2016 - 12/2013
2Bone Resorption
09/2015 - 09/2004
2Pain (Aches)
06/2015 - 03/2012
2Thrombocytopenia (Thrombopenia)
09/2014 - 12/2003
2Hyperthermia
09/2014 - 11/2011
2Carcinogenesis
08/2014 - 12/2013
2Triple Negative Breast Neoplasms
04/2014 - 04/2010

Drug/Important Bio-Agent (IBA)

27Trastuzumab (Herceptin)FDA Link
05/2022 - 12/2003
12Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2004
10VaccinesIBA
05/2022 - 07/2004
9Pharmaceutical PreparationsIBA
01/2022 - 05/2002
9Monoclonal AntibodiesIBA
01/2020 - 12/2003
9Biological ProductsIBA
08/2016 - 01/2004
8AntibodiesIBA
01/2020 - 12/2003
8Bevacizumab (Avastin)FDA Link
01/2017 - 05/2009
7AntigensIBA
07/2019 - 12/2003
7AnthracyclinesIBA
06/2015 - 05/2002
7Sunitinib (Sutent)FDA Link
02/2011 - 01/2007
6Peptides (Polypeptides)IBA
05/2022 - 12/2003
6Docetaxel (Taxotere)FDA Link
01/2017 - 08/2002
6Cetuximab (Erbitux)FDA Link
06/2015 - 11/2005
6Hormones (Hormone)IBA
11/2012 - 10/2003
5Capecitabine (Xeloda)FDA Link
01/2017 - 11/2003
5DNA (Deoxyribonucleic Acid)IBA
06/2015 - 06/2004
5Taxoids (Taxanes)IBA
06/2015 - 08/2002
5Vinorelbine (Navelbine)FDA LinkGeneric
10/2014 - 05/2006
5GemcitabineFDA Link
01/2010 - 05/2002
5Paclitaxel (Taxol)FDA LinkGeneric
07/2007 - 03/2002
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2006 - 05/2002
4Protein Subunit VaccinesIBA
05/2022 - 11/2007
4EpitopesIBA
01/2020 - 07/2004
4ErbB Receptors (EGF Receptor)IBA
01/2019 - 11/2005
4IntegrinsIBA
11/2015 - 12/2013
4Carcinoembryonic AntigenIBA
08/2014 - 03/2006
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2013 - 01/2007
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2008 - 02/2006
3B-Lymphocyte Epitopes (B-Cell Epitope)IBA
01/2021 - 11/2007
3Immune Checkpoint InhibitorsIBA
01/2020 - 08/2015
3Phosphotransferases (Kinase)IBA
01/2019 - 01/2007
3Tyrosine Kinase InhibitorsIBA
01/2019 - 11/2008
3Biomarkers (Surrogate Marker)IBA
08/2017 - 03/2010
3NivolumabIBA
01/2017 - 12/2014
3LigandsIBA
09/2015 - 12/2005
3Progesterone Receptors (Progesterone Receptor)IBA
10/2014 - 08/2007
3Rituximab (Mabthera)FDA Link
02/2014 - 01/2005
3Fulvestrant (Faslodex)FDA Link
09/2012 - 03/2006
3Sorafenib (BAY 43-9006)FDA Link
02/2011 - 11/2008
3CytokinesIBA
09/2010 - 09/2003
3Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2008 - 01/2005
3DecitabineFDA Link
01/2008 - 09/2005
3RetinoidsIBA
11/2007 - 06/2004
3Complement System Proteins (Complement)IBA
11/2007 - 12/2003
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2005 - 06/2002
3HMW-MAAIBA
07/2005 - 01/2005
3Fluorouracil (Carac)FDA LinkGeneric
12/2003 - 05/2002
2Messenger RNA (mRNA)IBA
12/2021 - 01/2017
2Neoplasm Antigens (Tumor Antigens)IBA
01/2020 - 02/2005
2Estrogen ReceptorsIBA
01/2019 - 10/2014
2MicroRNAs (MicroRNA)IBA
01/2018 - 03/2012
2Hemoglobins (Hemoglobin)IBA
09/2017 - 07/2005
2130-nm albumin-bound paclitaxelIBA
01/2017 - 08/2016
2PlatinumIBA
01/2017 - 03/2012
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2017 - 07/2009
2B7-H1 AntigenIBA
01/2016 - 08/2015
2Codon (Codons)IBA
06/2015 - 01/2012
2Protein Isoforms (Isoforms)IBA
10/2014 - 11/2007
2EnzymesIBA
09/2014 - 11/2008
2taxaneIBA
04/2014 - 12/2003
2Glycoproteins (Glycoprotein)IBA
11/2013 - 11/2007
2Lapatinib (GW572016)FDA Link
03/2013 - 06/2010

Therapy/Procedure

52Therapeutics
05/2022 - 10/2003
24Drug Therapy (Chemotherapy)
01/2017 - 01/2005
7Immunotherapy
01/2019 - 11/2003
6Radiotherapy
04/2012 - 01/2005
4Neoadjuvant Therapy
04/2014 - 03/2004
3Salvage Therapy
01/2017 - 10/2008
3Aftercare (After-Treatment)
02/2011 - 09/2005
3Combination Drug Therapy (Combination Chemotherapy)
01/2010 - 05/2002
2Precision Medicine
01/2022 - 01/2019
2Extracorporeal Circulation
09/2014 - 11/2011